|
NDUFB4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.94990000000384E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.227400E-04 |
| Normal-vs-Stage2 |
5.976000E-02 |
| Normal-vs-Stage3 |
2.246200E-01 |
| Normal-vs-Stage4 |
2.061200E-01 |
| Stage1-vs-Stage2 |
9.205600E-01 |
| Stage1-vs-Stage3 |
3.265800E-01 |
| Stage1-vs-Stage4 |
5.272000E-01 |
| Stage2-vs-Stage3 |
5.392600E-01 |
| Stage2-vs-Stage4 |
5.195200E-01 |
| Stage3-vs-Stage4 |
3.741400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.161430E-04 |
| Normal-vs-AfricanAmerican |
4.559400E-03 |
| Normal-vs-Asian |
9.328600E-01 |
| Caucasian-vs-AfricanAmerican |
5.791600E-01 |
| Caucasian-vs-Asian |
2.614800E-01 |
| AfricanAmerican-vs-Asian |
3.029600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.168110E-04 |
| Normal-vs-Female |
7.719000E-03 |
| Male-vs-Female |
8.474600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.969600E-02 |
| Normal-vs-Extreme_Weight |
5.243300E-04 |
| Normal-vs-Obese |
4.194000E-02 |
| Normal-vs-Extreme_Obese |
3.522400E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.022000E-01 |
| Normal_Weight-vs-Obese |
6.360000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.079200E-01 |
| Extreme_Weight-vs-Obese |
4.328800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.058800E-01 |
| Obese-vs-Extreme_Obese |
1.584950E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.311800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.387800E-04 |
| Normal-vs-Age(61-80Yrs) |
8.581200E-04 |
| Normal-vs-Age(81-100Yrs) |
5.356500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.719600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.755400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.417000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.558800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.330200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.924400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.6189999999815E-06 |
| Normal-VS-Type2 PRCC |
6.052400E-02 |
| Normal-VS-KIRP CIMP |
8.602000E-01 |
| Normal-VS-Unclassified PRCC |
7.782500E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.225700E-02 |
| Type1 PRCC-VS-KIRP CIMP |
7.476500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.785010E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.019800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.978200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.789800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.132300E-02 |
| Normal-vs-N1 |
3.359600E-01 |
| Normal-vs-N2 |
7.275800E-01 |
| N0-vs-N1 |
6.598200E-01 |
| N0-vs-N2 |
9.517200E-01 |
| N1-vs-N2 |
8.764800E-01 |
|
|
